Treatment of syndrome of croup in children on prehospital stage

Abstract

The aim is to demonstrate the pharmacoeconomical feasibility of using inhaled glucocorticosteroids in high doses in the provision of medical care to patients with acute stenosing laryngotracheitis at the prehospital stage. Materials and methods. For the period from 2011 to 2016 were reviewed 46 discharge instructions discharge summaries of children and 221 card call to patients with syndrome of croup from January to September 2015. Results and discussion. It was found that mild forms of syndrome of croup prevailed among the hospitalized patients, while the average duration of inpatient treatment was 6.2 days. Most of the drugs, prevailed at all stages appointed, pathogenetically unreasonable in the provision of emergency care for mild forms of syndrome of croup. Only 78.7% of patients received nebulizer therapy with budesonide, mainly in low doses. The use of high doses of budesonide had a more pronounced clinical effect on reducing the severity of respiratory failure. Conclusions. The use of high-dose inhalation corticosteroids, allows you to quickly stop respiratory failure at home and avoid hospitalization, which has significant pharmacoeconomical advantages compared to inpatient treatment.